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Some di- and tripeptidesof L- and D-pipecolic acid, fragments of the corresponding pipecolic 
acid-bradykinin analogues, a^LÎescribed. 
Changes in the structure of known peptide hormones by substituting amino 
acids of similar character for the constituting amino acids are very important for 
the investigation of the connections between hormone structure and biological 
activity [1]. Among the amino acids substituted several "non-proteinogenic" amino 
acids [2] are found, mainly as corresponding homologues of "proteinogenic" 
amino acids. 
Proline is an important constituent of several biologically active peptide 
hormones. Three of the nine amino acids contained in the well-known tissue 
hormone Bradykinin (I) are prolines: 
Thus it is easy to see that the use of proline homologues in peptide chemistry may 
yield much valuable information. The most important homologues to be considered 
in their optically active form are pipecolic acid*, azetidine-2-carboxylic acid, 
oxazolidine-4-carboxylic acid, thiazolidine-4-carboxylic acid and a-homoproline. 
According to literature, oxazolidine-4-carboxylic acid has not been used in 
peptide chemistry owing to various circumstances, and only in three instances 
[3, 4, 17c] the use of azetidine-2-carboxylic acid is found; three papers [3—5] 
were published on the substitution of thiazolidine-4-carboxylic acid, while a-homo-
proline was applied only most recently, after a suitable way of synthesis had been 
elaborated [6]. 
* The abbrevations are those accepted by IUPAC—IUB for peptide chemistry: Pip = pipecolic 
acid (piperidine-2-carboxylic acid); Aze=azetidine-2-carboxylic acid; Thz=thiazolidine-4-carboxy-
lic acid; Oxz = oxazolidine-4-carboxylic acid; HPro = a-homoprolin (pyrrolidine-2-acetic acid). 
Z=benzyloxycarbonyl; Boc=/-butyloxycarbonyl; ONb=p-nitrobenzyl. 
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Pipecolic acid was applied more frequently than the above amino acids, mainly 
in connection with the preparation of the corresponding analogues. The first 
papers on this topic were- concerned with collagen models [7] and 3-L-pipecolic 
acid-bradykinin [8]. Then the synthesis of 7-L-pipecolic acid-oxytocin [9] followed. 
All these publications give very little information on the synthetic work, therefore 
it seemed justified to elaborate a suitable resolution method for preparing optically' 
active pipecolic acids and derivatives suitable for peptide chemical purposes [10]. 
At the same time with our paper [10a] the first use of pipecolic acid in solid phase 
peptide synthesis for preparing 7-L-pipecolic acid-angiotensine II was describecTfll]. 
In the last years, several papers concerning the use of pipecolic acid for preparing 
sequence-polypeptides [3] as well as pipecolic acid-bradykinin analogues, both 
with solid-phase and conventional peptide synthesis [12, 13], are found/in literature. 
In the total synthesis of an analogue of the antibiotic Penicillin^cephalosporin, 
too [14], an optically active pipecolic acid derivative was used:.- Most recently, 
isolation and structure determination of Actinomycin [15] and Amphomycin [16] 
also points to the presence of optically active pipecolic acids, fhe structure support-
ing syntheses are to be expected in the next future. . 
During the synthetic work aiming at the preparat io^of pipecolic acid-brady-
kinin analogues, numerous di- and tripeptides containing pipecolic acids were 
prepared in our research group. The present paper wishes to review the latter and 
to compare them with the results other authors of, published after our work had 
been finished [17a—c]. 
The dipeptides containing L- and D-pipecolic acids were prepared (Table I) 
with the mixed anhydride method [18] to obtain protected dipeptide esters (1—4), 
or by. acylating the salt of the amino component with the N-hydroxysuccinimid 
esters of the protected acyl component [19] to form protected dipeptides (5—7). 
For comparison, in the case of two protected dipeptide esters (1 and 2) the corre-
sponding protected dipeptides were prepared by alkaline hydrolysis (6 and 7), too. 
From the corresponding dipeptide derivatives the C-terminal (8—11) and N-ter-
minal (12—13) protected tripeptide esters or protected tripeptides (Table II) used 
for the synthesis of the pipecolic acid-bradykinin analogues were also prepared 
with the mixed anhydride method. The preparation of greater fragments obtained 
from the latter or with other methods will be described in a subsequent paper [20] 
Experimental 
Melting points were determined with a Kofler block, optical rotations with 
a Zeiss polarimeter. The values given are uncorrected. TLC on Kiesel G (Merck) 
was used for purity control with the following systems: 
1. «-butanol—acetic acid—water 4:1:1 
2. ethyl acetate—pyridine—acetic acid—water 60:20:6:11 
3. chloroform—methanol 8:2 
4. chloroform—methanol—acetic acid 85:10:5. 
Methyl benzyloxycarbonyl-L-pipecolyl-L-pipecolate (1). 14.48 g (55 mmole) 
benzyloxycarbonyl-L-pipecolic acid, solved in 75 ml chloroform, wás cooled to 
— 15°C. 6.05 ml (55 mmole) N-methylmorpholine and 5.28 ml (55 mmole) ethyl 
•chloroformate was added dropwise to the cooled solution. After three minutes 
.stirring 9.98 g (50mmole) methyl L-pipecolinate hydrochloride and 5.55 ml (50mmole) 
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N-methylmorpholine, both solved in 75 ml chloroform and cooled, were added 
to the reaction mixture and the stirring continued at — 5°C for 3 hrs, then at room 
temperature for 2 hrs. After standing in a refrigerator overnight, the small amount 
of precipitated N-methylmorpholine hydrochloride .was filtered off, the solution 
evaporated and the rest solved in ethyl acetate. The solution was washed with 
diluted sodium hydrocarbonate, diluted hydrochloric acid, then With water. After 
drying, the ethyl acetate solution was evaporated to obtain an oil, which was 
crystallized. 
Benzyloxycarbonyl-L-pipecolyl-D-pipecolic acid (7). 7.2 g (20 mmole) N-hydroxy-
succinimide benzyloxycarbonyl-L-pipecolate and 3.25 g (25 mmole) D-pipecolic acid 
were solved in a mixture of 15 ml water and 15 ml pyridine. The reaction mixture 
was brought to pH 8.8 by adding AN sodium hydroxide under continuous stirring 
and held at the same pH for 3 hrs. Then the solution was adjusted to pH 8.0 by 
adding AN hydrochloric acid, saturated with solid sodium hydrocarbonate and 
extracted with ethyl acetate. The aqueous solution was acidified to pH 2.0 with 
AN hydrochloric acid and the precipitate solved in ethyl acetate, washed with, water 
and dried, the ethyl acetate evaporated in vacuum and the oil obtained was 
crystallized. 
p-Nitrobenzyl t-butyIoxycarbonyl-D-pipecolyl-L-phenylalanyl-L-nitroargininate(W). 
Trifluoroacetate of /?-nitrobenzyl-L-phenylalanyl-L-nitroargininate, obtained from 
the protected compound with trifluoroaCetic acid, was solved in 30 ml dimethyl-
formamide and 1.33 ml (12 mmole) N-methylmorpholine was added to the 
solution. Then, after 1 minute, 3.26 g (10 mmole) N-hydroxysuccinimide ?-butyl-
oxycarbonyl-D-pipecolinate was added under stirring. After 24 hrs stirring at room 
temperature the reaction mixture was poured in water and the suspension obtained 
solved in ethyl acetate, the cooled ethyl acetate solution rapidly washed with diluted 
hydrochloric acid, diluted sodium hydrocarbonate and water. After drying arid evap-
orating, an oil was obtained, which was crystallized. 
Benzyloxycarbonyl-L-nitroarginyl-L-pipecolyl-L-pipecolic acid (13). 4.2 g (12 
mmole) benzyloxycarbonyl-L-nitroarginine was solved in 15 ml dimethylform-
.amide, the solution cooled under — 15°C, then 1.33 ml (12 mmole) N-methylmor-
pholine and 1.15 ml ethyl chloroformate were added dropwise. After 3 minutes, 
the cooled solution of dipeptide hydrochloride (Ry(l) = 0.5, Ry(3)=0.35) was added 
to the reaction mixture. The dipeptide hydrochloride solution was prepared in 
advance from 3.74 g (10 mmole) benzyloxycarbonyl-L-pipecolyl-L-pipecolic acid (6), 
solved in hydrochloric acid—metanol, by hydrogenation in the presence of Pd-C 
catalyst, then solving in 15 ml dimethylformamide and adding 1.11 ml (10 mmole) 
N-methylmorpholine. The reaction mixture was stirred at a temperature lower 
than — 5°C for 3 hrs and held in a refrigerator overnight. The solution was evaporated 
in vacuum and the remaining oil digerated with diluted sodium hydrocarbonate and 
0.1./V hydrochloric acid, filtered, washed several times with diluted sodium hydro-
carbonate solution, diluted hydrochloric acid, water and finally with ether, then 
crystallized. 
The authors are indebted to thanks to Mrs. G . BARTOK-BOZOKI and Mrs. E . 
GACS-GERGELY for elemental analysis and to Miss I . BAGI for technical assistance. 
Table I 
Physical properties of dipeptides* 










C H N 
Z-L-Pip-L-Pip-OMe (1) MA EtOH—petroleum ether 69 67—70 - 6 2 64.9 7.3 7.2 64.9 7.3 7.1 
Z-L-Pip-D-Pip-OMe** (2) MA EtOH—petroleum ether 78 56—59 + 16 64.9 7.3 7.2 64.8 7.3 7.0 
Z-D-Pip-L-Pip-OMe (3) MA EtOH—petroleum ether 75 66—68 + 18 64.9 7.3 7.2 64.8 7.3 7.1 
Z-D-Pip-D-Pip-OMe*** (4) MA EtOH—petroleum ether 81 64—66 + 64 64.9 7.3 7.2 64.8 7.3 7.0 
Z-L-Pip-L-Pro-OH (5) SuOH MeOH 68 170—173 - 7 2 63.3' 6.7 7.8 63.1 6.7 7.6 








- 5 8 
- 5 7 
64.1 7.0 7.5 
64.0 6.9 7.5 
63.8 6.9 7.4 










64.1 7.0 7.5 
64.0 6.9 7.3 
64.1 6.9 7.4 
* E tOH=ethano l ; MeOH = methanol; SuOH=N-hydroxysuccinimide activated ester; MA = mixed anhydride; hydrolysis-ester 
hydrolysis 
** [17] DCC1 method, oil, [a]|>0 = + 22.6°C (c=0.15, in methanol). Found: C: 64.70 H : 6.82, N : 7.47% 
*** [17] DCC1 method, m.p. 61—62.5°C, [ 0 ® = +76.6° (c=0.4, in methanol). Found: C: 64.8, N : 7.34, N : 7.02% 
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СИНТЕЗ ДИ- И ТРИПЕПТИДОВ В СОСТАВЕ НЕСКОЛЬКИХ 
МОЛЕКУЛ ОПТИЧЕСКИ АКТИВНОЙ ПИПЕКОЛИНОВОЙ КИСЛОТЫ, 
КОТОРЫЕ СООТВЕТСТВУЮТ ФРАГМЕНТАМ АНАЛОГОВ Б Р А Д И К И Н И Н А 
С ПИПЕКОЛИНОВОЙ КИСЛОТОЙ 
Л. Балашпири, Дь. Папп, П. Паллаи, К. Ковач 
Авторы сообщают синтез и физические константы ди- и трипептидов, в составе нес-
кольких молекул пипеколиновой кислоты „Ъ" и „ Б " , которые соответствуют фрагментам 
аналогов брадикинина с пипеколиновой кислотой. 
